Hvis der udvikles grad 3 sensorisk neuropati, anbefales det at stoppe behandlingen, indtil den er faldet til grad 1 eller 2, hvorefter dosis reduceres i alle efterfølgende Abraxane- behandlinger (se afsnit 4. 2).
If grade 3 sensory neuropathy develops, treatment should be withheld until resolution to grade 1 or 2 followed by a dose reduction for all subsequent courses of Abraxane is recommended (see section 4.2).